Systematic evaluation of connectivity map for disease indications

Genome Medicine

Volumn 6, Issue 12, 2014, Pages

  Cheng, Jie ^a   Yang, Lun ^a   Kumar, Vinod ^a   Agarwal, Pankaj ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; BREAST CANCER; CONNECTIVITY MAP; CONTROLLED STUDY; DATA PROCESSING; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG REPOSITIONING; GENE EXPRESSION; HL 60 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; PRIORITY JOURNAL; SYSTEMATIZED NOMENCLATURE OF MEDICINE;

EID: 84927724806     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0095-1     Document Type: Article

References (28)

1. Dudley JT, Deshpande T, Butte AJ: Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform 2011, 12:303-311.
2. Suthram S, Dudley JT, Chiang AP, Chen R, Hastie TJ, Butte AJ: Networkbased elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol 2010, 6:e1000662.
3. Hu G, Agarwal P: Human disease-drug network based on genomic expression profiles. PLoS One 2009, 4:e6536.
4. Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, Sage J, Butte AJ: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 2011, 3:96-77.
5. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR: The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
6. Qu XA, Rajpal DK: Applications of Connectivity Map in Drug Discovery and Development. Drug Discov Today 2012, 17:1289-1298.
7. Chang M, Smith S, Thorpe A, Barratt MJ, Karim F: Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping. Mol Pain 2010, 6:56.
8. Claerhout S, Lim JY, Choi W, Park YY, Kim K, Kim SB, Lee JS, Mills GB, Cho JY: Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer. PLoS One 2011, 6:e24662.
9. Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, Morgan AA, Sarwal MM, Pasricha PJ, Butte AJ: Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med 2011, 3:96-76.
10. Ishimatsu-Tsuji Y, Soma T, Kishimoto J: Identification of novel hair-growth inducers by means of connectivity mapping. FASEB J 2010, 24:1489-1496.
11. Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, Malmberg SE, Alipour F, Shields RK, Adams CM: mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 2011, 13:627-638.
12. Jin L, Tu J, Jia J, An W, Tan H, Cui Q, Li Z: Drug-repurposing identified the combination of Trolox C and Cytisine for the treatment of type 2 diabetes. J Transl Med 2014, 12:153.
13. Gottlieb A, Stein GY, Ruppin E, Sharan R: PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 2011, 7:496.
14. Iskar M, Campillos M, Kuhn M, Jensen LJ, van Noort V, Bork P: Drug-induced regulation of target expression. PLoS Comput Biol 2010, 6:e1000925.
15. Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, Ferriero R, Murino L, Tagliaferri R, Brunetti-Pierri N, Isacchi A, di Bernardo D: Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci U S A 2010, 107:14621-14626.
16. Cheng J, Xie Q, Kumar V, Hurle M, Freudenberg JM, Yang L, Agarwal P: Evaluation of analytical methods for connectivity map data. Pac Symp Biocomput 2013, 18:5-16.
17. Cheng J, Yang L: Comparing gene expression similarity metrics for connectivity map. In Proceedings of IEEE International Conference on Bioinformatics and Biomedicine: 18-21 Dec. 2013, Shanghai, China. Edited by Li G, Hu X, Kim S, Ressom H, Hughes M, Liu B, McLachlan G, Liebman M, Sun H. New York: IEEE; 2013:165-170.
18. The Connectivity map 02. [http://www.broadinstitute.org/cmap/]
19. Affymetrix. [http://www.affymetrix.com]
20. Genelogic. [http://www.ocimumbio.com/bioexpress-system/]
21. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.
22. Pharmaprojects. [http://www.citeline.com/products/pharmaprojects/]
23. Unified Medical Language System. [http://www.nlm.nih.gov/research/umls/]
24. FDA Adverse Event Reporting System (FAERS). [http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/]
25. Zhang SD, Gant TW: A simple and robust method for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics 2008, 9:258.
26. Pacini C, Iorio F, Gonalves E, Iskar M, Klabunde T, Bork P, Saez-Rodriguez J: DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data. Bioinformatics 2013, 29:132-134.
27. Cheng J, Greshock J, Shi L, Zheng S, Menius A, Lee K: Good practice guidelines for biomarker discovery from array data: a case study for breast cancer prognosis. BMC Syst Biol 2013, 7:S2.
28. Vempati UD, Chung C, Mader C, Koleti A, Datar N, Vidovic D, Wrobel D, Erickson S, Muhlich JL, Berriz G, Benes CH, Subramanian A, Pillai A, Shamu CE, Schrer SC: Metadata standard and data exchange specifications to describe, model, and integrate complex and diverse high-throughput screening data from the Library of Integrated Network-based Cellular Signatures (LINCS). J Biomol Screen 2014, 19:803-816.